CATCH ALL Clinical Research Unit 5010 jobs and careers

About CATCH ALL Clinical Research Unit 5010

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and adults. CATCH ALL aims to understand why survival rates drop as patients age and develop better therapies. The DFG-funded clinical research unit investigates how the immune system and leukemia cells interact, with a focus on age-specific factors. Kiel has a distinctive research environment, highlighted by the presence of the leading ALL study groups AIEOP-BFM and GMALL. Consequently, ALL serves as an age-overriding model disease in both clinical care and basic research.